The Food and Drug Administration (FDA) has granted Orphan Drug designation to BA-102 for the treatment of Phelan-McDermid syndrome, a rare neurodevelopmental disorder linked to autism.

Beyond Air (NASDAQ:XAIR) said on Thursday that the United States Patent and Trademark Office (USPTO) has issued a U.S. Patent ...

Beyond Air (XAIR) announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,274,830. The issued patent gives ...

Nitric oxide (NO) is a gaseous signalling molecule that is involved in the regulation of the cardiovascular, immune and nervous systems. In the CNS, NO is involved in many processes, including the ...